SynopsisThe global Cerebroprotein Hydrolysate market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026. This report focuses on Cerebroprotein Hydrolysate volume and value at.....
SynopsisThree dimensional (3D) bioprinting is the utilization of 3D printing and 3D printing–like techniques to combine cells, growth factors, and biomaterials to fabricate biomedical parts that maximally imitate natural tissue characteristics. Generally, 3D bioprinti.....
SynopsisBicalutamide is a non-steroidal antiandrogenic drug, which is used in combination with luteinizing hormone releasing hormone (LHRH) analogues or surgical orchiectomy in the treatment of advanced prostate cancer.Bicalutamide first by oral absorption good.There .....
SynopsisPlasma bilirubin adsorber is a medical device used in the treatment of hyperbilirubinemia, a condition characterized by high levels of bilirubin in the blood Global Plasma Bilirubin Absorber market is projected to reach US$ million in 2029, increasing fr.....
SynopsisThe global Disposable Resin Hemoperfusion Cartridge market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were consi.....
SynopsisThe global Supplements for Hormone Balance market was valued at US$ 12 million in 2023 and is anticipated to reach US$ 18 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030. The market for supplements for hormone balance has .....
SynopsisThe global Subcutaneous Injector market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Subcutaneous Injector in various end use industries. The expanding d.....
SynopsisTotal Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and.....
SynopsisPre-clinical (in-vivo) imaging is bridging a gap between the vivo clinical research and vitro exploratory. It is increasingly being deployed across the drug development process, specifically in oncology therapeutic area. The advanced research and development f.....
SynopsisOff-the-shelf Automated System is an automated platform designed to improve the quality, speed and cost of multiple balloon catheter and stent delivery production processes. The global Off-the-shelf Automated System market was valued at US$ 1286 million .....
